A
Andreas P. Kalogeropoulos
Researcher at Stony Brook University
Publications - 33
Citations - 364
Andreas P. Kalogeropoulos is an academic researcher from Stony Brook University. The author has contributed to research in topics: Heart failure & Ejection fraction. The author has an hindex of 7, co-authored 33 publications receiving 173 citations. Previous affiliations of Andreas P. Kalogeropoulos include University of Patras & Brigham and Women's Hospital.
Papers
More filters
Journal ArticleDOI
High-dose methylprednisolone in nonintubated patients with severe COVID-19 pneumonia.
Aikaterini Papamanoli,Jeanwoo Yoo,Prabhjot Grewal,William Predun,Jessica Hotelling,Robin Jacob,Azad Mojahedi,Hal Skopicki,Mohamed Mohsen Mansour,Luis A. Marcos,Andreas P. Kalogeropoulos +10 more
TL;DR: Recent trials with dexamethasone and hydrocortisone have demonstrated benefit in patients with coronavirus disease 2019 (COVID‐19) and data on methylprednisolone is limited.
Journal ArticleDOI
Antihyperglycemic Therapies With Expansions of US Food and Drug Administration Indications to Reduce Cardiovascular Events: Prescribing Patterns Within an Academic Medical Center
Arsalan Hamid,Muthiah Vaduganathan,Adebamike A Oshunbade,Krishna K. Ayyalasomayajula,Andreas P. Kalogeropoulos,Lillian F. Lien,Tariq Shafi,Michael E. Hall,Javed Butler +8 more
TL;DR: Prescription of evidence-based therapies to improve CVD outcomes in high-risk patients with T2DM remains very low after several years of evidence generation.
Journal ArticleDOI
Diastolic Dysfunction in Individuals With Human Immunodeficiency Virus Infection: Literature Review, Rationale and Design of the Characterizing Heart Function on Antiretroviral Therapy (CHART) Study.
Javed Butler,Andreas P. Kalogeropoulos,Kevin J. Anstrom,Priscilla Y. Hsue,Raymond J. Kim,Rebecca Scherzer,Sanjiv J. Shah,Svati H. Shah,Eric J. Velazquez,Adrian F. Hernandez,Patrice Desvigne-Nickens,Eugene Braunwald +11 more
TL;DR: This study will compare ART-treated virally suppressed HIV-infected individuals with and without DD and HIV- individuals with DD regarding systemic inflammation, myocardial stress, and subclinicalMyocardial necrosis as indicated by circulating biomarkers.
Journal ArticleDOI
Cardiomyopathy and Heart Failure in Patients With HIV Infection
TL;DR: The pre-ART phenotype of HIV-associated cardiomyopathy with overt left ventricular systolic dysfunction and poor prognosis has been replaced over time by cardiopathy with a more insidious course, more frequent ischemic background, and highly prevalentleft ventricular diastolic dysfunction.
Journal ArticleDOI
Diastolic Dysfunction in Patients With Human Immunodeficiency Virus Receiving Antiretroviral Therapy: Results From the CHART Study
Javed Butler,Stephen J. Greene,Svati H. Shah,Sanjiv J. Shah,Kevin J. Anstrom,Raymond J. Kim,Andreas P. Kalogeropoulos,Eric J. Velazquez,Adrian F. Hernandez,Patrice Desvigne-Nickens,Rebecca Scherzer,Priscilla Y. Hsue,Eugene Braunwald +12 more
TL;DR: In this contemporary HIV+ population receiving antiretroviral therapy, DD was associated with multiple alterations in cardiac structure and function, including myocardial fibrosis and left atrial abnormalities, and worse quality of life.